Rockwell Medical Inc. buy elfe
Start price
06.07.14
/
50%
€97.60
Target price
04.08.14
€110.00
Performance (%)
-11.78%
End price
04.08.14
€86.11
Summary
This prediction ended on 04.08.14 with a price of €86.11. The prediction for Rockwell Medical Inc. disappointed with a performance of -11.78%. elfe has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Rockwell Medical Inc. | - | - | - | - |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
Comments by elfe for this prediction
In the thread Rockwell Medical Inc. diskutieren
Rockwell Medical erhält FDA -Zulassung für Calcitriol.
Der Anfang ist gemacht, die Zulassung für Vitamin D Injektionsglässer zu Vermarkten.
Marktplazierung: 363 Milionen
Anzahl der Aktien 41 Milionen
Für Anleger mit langfristiger Strategie, Kaufsignal.
(Vom Mitglied beendet)